BC exhibits high heterogeneity and is classified into several subtypes according to genetic and clinical characteristics, including luminal A, luminal B, triple-negative breast cancer (TNBC), and HER2 enrichment [5,6,7,8,9]. This evidence concerns the gene ERBB2 and breast cancer.